Cryotherapy for prostate cancer

References

• Onik GM, Cohen JK, Reyes GD et al Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer72, 1291–1299 (1993).
   PubMed Web of Science ®Google Scholar
• Rubinsky B. The freezing process and mechanism of tissue damage. In: Percutaneous Prostate Gyoablation. Onik GM, Rubinsky B, Watson F, Albin RJ (Eds). Quality Medical Publishing, St Louis, MO, USA, 49 (1995).
   Google Scholar
• Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann. Rev. Coll Surg. Engl. 66,313–318 (1984).
   PubMed Web of Science ®Google Scholar
• Frase J, Gill W Observations on ultra frozen tissue. Br. Sing 54,770–776 (1967).
   Google Scholar
• Hayakawa K, Yamashita T, Suzuki K et al Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology 42,59–68 (2001).
   Google Scholar
• Mazur P. Cryobiology: the freezing of biological systems. Science 168,939–949 (1970).
   Google Scholar
• Carroll PR, Lee Kl, Fuks ZY et al. Cancer of the prostate. In: Principles and Practice of Oncology 6th Edition. Devita VT Hellman S, Rosenberg SA (Eds). Lippincott, Williams and Wilkins, PA, USA, 1456 (2000).
   Google Scholar
• Tatsutani K, Rubinsky B, Onik G et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. J. Ural 48,441–447 (1996).
   Google Scholar
• Bischof JC, Fahssi WM, Smith DJ et al. A parametric study of freezing injury in ELT-3 uterine leiomyoma tumor cells. Hum. Reprod 16,340–348 (2001).
   Google Scholar
• McGrath JJ, Cravalho EG, Huggins CE. An experimental comparison of intracellular ice formation and freeze-thaw survival of HeLa S-3 cells. Cryobiology12, 540–550 (1975).
   Google Scholar
• Zacarian SA. The observation of freeze- thaw cycles upon cancer cell suspensions. Dermatol Surg. Oncol 3, 173–174 (1977).
   Google Scholar
• Jacob G, Kurzer MN, Fuller BJ. An assessment of tumor cell viability after in Oho freezing. Gyobiology22, 417–426 (1985).
   Google Scholar
• Yang WH, Peng HH, Chang HC et al. An in vitro monitoring system for simulated thermal process in cryosurgery. Cryobiology 40, 159–170 (2000).
   Google Scholar
• Kremer C, Duffy S. hi vitro studies of cryoablation of the endometrium. Am. J. Obstet. Cynecol 183,22–27 (2000).
   Google Scholar
• Mazur P. Freezing of living cells: mechanisms and implications. Am. J. Physiol 143, C125–C142 (1984).
   Google Scholar
• Steponkus PL. Role of the plasma membrane in freezing injury and cold acclimation. Ann. Rev. Plant Physiol 35, 543–584 (1984).
   Google Scholar
• Lovelock JE, The haemolysis of human red blood cells by freezing and thawing. Biochem. Biophys. Acta 10,414–426 (1953).
   PubMed Web of Science ®Google Scholar
• Smith DJ, Fahssi WM, Swanlund DJ et al. A parametric study of freezing injury in AT-1 rat prostate tumor cells. Cryobiology 39, 13–28 (1999).
   Google Scholar
• Toner M. Nucleation of ice crystals inside biological cells. In: Advances in Low-Temperature Biology Steponkus P (Ed.). JAI Press, London, UK, 1–52 (1993).
   Google Scholar
• Asahina E, Shimada K, Hisada Y. A stable state of frozen protoplasm with invisible intracellular ice crystals obtained by rapid cooling. Exp. Cell. Res. 59,349–358 (1970).
   Google Scholar
• Larson TR, Robertson DW, Corica A et al. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 55, 547–552 (2000).
   PubMed Web of Science ®Google Scholar
• Schmidt JD, Doyle J, Larison S. Prostate cryoablation: update 1998. CA Cancer J. Clin. 48,239-253 (1998).
   Google Scholar
• Perrotte P, Litwin MS, McGuire EJ et al. Quality of life after salvage cryotherapy: the impact of treatment parameters. J. Ural 162,398–402 (1999).
   Google Scholar
• Sesia G, Ferrando U, Fontana G et al. Palliative cryotherapy in inoperable prostate carcinoma. Recent Results Cancer Res. 60, 84–90 (1977).
   Google Scholar
• Chang Z, Finkelstein JJ, Ma H et al Development of a high-performance multiprobe cryosurgical device. Biomed Instrum. Technol 28,383–390 (1994).
   Google Scholar
• Lee F, Bahn DK, Badalament RA et al. Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Urology 54,135–140 (1999).
   PubMed Web of Science ®Google Scholar
• Pisters LL, Von Eschenbach AC. Cryotherapy for the prostate. In: Advances in Urology McGuire EJ, Bloom D, Catalona WJ, Lytton B (Eds). Mosby-Year Book, St Louis, MO, USA, 97 (1995).
   Google Scholar
• De La Taille A, Benson MC, Bagiella E et al Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU. Int. 85,281–286 (2000).
   Google Scholar
• Koppie TM, Shinohara K, Grossfeld GD et al The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J. Ural 162,427–432 (1999).
   Google Scholar
• Lee F, Balm DK, McHugh TA et al Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring: a one year follow-up. Anticancer Res. 17,1511–1515 (1997).
   Google Scholar
• Cohen JK, Miller RJ, Rooker GM, Shuman BA. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology47, 395–401 (1996).
   PubMedGoogle Scholar
• Coogan CL, McKiel CF. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. j Ural 154, 1813–1817 (1995).
   Google Scholar
• Bahn DK, Lee F, Solomon MET et al Prostate cancer: US-guided percutaneous cryoablation. Work in progress. Radiology 194(2), 551–556 (1995).
   Google Scholar
• Wieder J, Schmidt JD, Casola G et al. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J. Ural 154 (2, Pt 1), 435–441 (1995).
   Google Scholar
• Miller RJ, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical Stage C adenocarcinoma of the prostate. Urology 44,170–174 (1994).
   Google Scholar
• Saliken JC, Donnelly BJ, Brasher P et al Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer. j Vasc. Interv. Radial 10(2, Pt 1), 199–208 (1999).
   Google Scholar
• Ellis DS. Cryotherapy as primary treatment for localized prostate cancer: a community hospital experience. Umlogy60(2A), 34 (2002).
   Google Scholar
• Shinohara K, Carroll PR. Improved results of cryosurgical ablation of the prostate. J. Ural 153,627A (1995).
   Google Scholar
• Cohen JK, Miller RJ Jr, Shuman BA. Cryosurgical ablation of the prostate: patterns of failure and two year post treatment data as compared to external beam radiation therapy. J. Ural 153, 1098A (1995).
   Google Scholar
• Hanno P, Brandes S, Stern R et al. Persistence of histologically viable appearing prostate tissue after cryosurgery. J. Ural 153,1099A (1995).
   Google Scholar
• Balm DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology60(2, Suppl. 1), 3–11 (2002).
   Google Scholar
• Donnelly BJ, Saliken JC, Ernst DS et al Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60, 645–649 (2002).
   PubMedGoogle Scholar
• Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Umlogy 60,109–114 (2002).
   Google Scholar
• Connolly JA, Shinohara K, Carroll PR. Cryosurgery for locally advanced (T3) prostate cancer. Semin. Ural Oncol 15, 244–249 (1997).
   Google Scholar
• Connolly JA, Shinohara K, Presti JC Jr, Carroll PR. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Ural Clin. North Am. 23, 623 (1996).
   Google Scholar
• Derakhshani P, Neubauer S, Braun M et al Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results. Eur Ural 34,181–187 (1998).
   Google Scholar
• Porter MP, Ahaghotu CA, Loening SA, See WA. Disease-free and overall survival after cryosurgical monotherapy for clinical Stages B and C carcinoma of the prostate: a 20-year follow-up. J. Ural 158(4), 1466–1469 (1997).
   Google Scholar
• Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology45,932–935 (1995).
   Google Scholar
• Badalament RA, Balm DK, Kim H et al Patient-reported complications after cryoablation therapy for prostate cancer. Arch. Ital. Ural Andml 72,305–312 (2000).
   Google Scholar
• de La Taille A, Hayek 0, Benson MC et al Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Umlogy55, 79–84 (2000).
   Google Scholar
• Aboseif S, Shinohara K, Borirakchanyavat S et al The effect of cryosurgical ablation of the prostate on erectile function. BE j UE01. 80,918–922 (1997).
   Google Scholar
• Rogers E, Ohori M, Kassabian VS et al Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J. Um/. 153,104–110 (1995).
   Google Scholar
• Lerner SE, Blute ML, Zincke H. Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J. Ural 154,1103–1109 (1995).
   Google Scholar
• Russo P. Salvage radical prostatectomy after radiation therapy and brachytherapy. Endourol 14,385–390 (2000).
   Google Scholar
• Pisters LL, von Eschenbach AC, Scott SM et al The efficacy and complications of salvage cryotherapy of the prostate. I. Um/157,921–925 (1997).
   Google Scholar
• Miller RJ, Cohen JK, Shuman B, Merlotti LA. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma. Cancer 77,1510–1514 (1996).
   PubMedGoogle Scholar
• Bales GT, Williams MJ, Sinner M et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology46, 676–680 (1995).
   Google Scholar
• Pisters LL, Perrotte P, Scott SM et al Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J. Clin. Oncol 17, 2514–2520 (1999).
   Google Scholar
• Ghafar MA, Johnson CW, de La Taille A et al Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J. Ural 166, 1333–1337 (2001).
   Google Scholar